Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM4 | Q14833 | 3/20 | 0.34 |
| ▸ | JAK2 | O60674 | 10/20 | 0.34 |
| ▸ | JAK1 | P23458 | 9/20 | 0.34 |
| ▸ | JAK3 | P52333 | 4/20 | 0.34 |
| ▸ | GCG | P01275 | 2/20 | 0.32 |
| ▸ | TYK2 | P29597 | 2/20 | 0.32 |
| ▸ | AURKA | O14965 | 1/20 | 0.32 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.32 |
| ▸ | INCENP | Q9NQS7 | 1/20 | 0.32 |
| ▸ | TPX2 | Q9ULW0 | 1/20 | 0.32 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29567583 | 1.00 | GRM4 (0.34) | GRM4JAK2JAK1JAK3GCG | |
| SCHEMBL22716878 | 0.90 | GCG (0.33) | GRM4JAK2JAK1JAK3GCG | |
| SCHEMBL29567490 | 0.90 | GCG (0.33) | GRM4JAK2JAK1JAK3GCG | |
| SCHEMBL29568051 | 0.89 | JAK2 (0.33) | GRM4JAK2JAK1JAK3GCG | |
| SCHEMBL29568285 | 0.89 | JAK2 (0.33) | GRM4JAK2JAK1JAK3GCG | |
| SCHEMBL22735791 | 0.89 | JAK2 (0.33) | GRM4JAK2JAK1JAK3GCG | |
| SCHEMBL22736486 | 0.89 | JAK2 (0.33) | GRM4JAK2JAK1JAK3GCG | |
| SCHEMBL29480694 | 0.89 | JAK2 (0.33) | GRM4JAK2JAK1JAK3GCG | |
| SCHEMBL22736256 | 0.88 | GCG (0.32) | GRM4JAK2JAK1JAK3GCG | |
| SCHEMBL29567135 | 0.88 | GCG (0.32) | GRM4JAK2JAK1JAK3GCG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020240586-A1 | NOVEL COMPOUNDS FOR INHIBITION OF JANUS KINASE 1 | MANKIND PHARMA LTD. (IN) | 2020-12-03 | — | — | WO | disclosed |